In homogeneous catalysis, the catalyst is in the same phase as the reactant. The number of collisions between reactants and catalyst is at a maximum.In a patent, 763114-26-7, name is 2-Fluoro-5-((4-oxo-3,4-dihydrophthalazin-1-yl)methyl)benzoic acid, introducing its new discovery. Recommanded Product: 2-Fluoro-5-((4-oxo-3,4-dihydrophthalazin-1-yl)methyl)benzoic acid
Amino-substituted tetrahydro pyrido pyrimidine compound or its salts and its preparation method and application (by machine translation)
The invention discloses an amino substituted tetrahydro pyrido pyrimidine compound or its salts and its preparation method and application. The compound or its salts having the following general structure or , Wherein R1 , R2 Is C1 – 5 alkyl or amino; R3 With a N 5 – 6 […] members of the heterocyclic radical, the heterocyclic substituent is a nitrogen-containing, containing alkyl-substituted nitrogen or oxygen-containing heterocyclic group. The compound or its pharmaceutically acceptable salt has potent PARP1 inhibitory activity, can be used for treating diseases or cancer drug used for prevention and/or treating PARP1 related diseases. (by machine translation)
We¡¯ll also look at important developments in the pharmaceutical industry because understanding organic chemistry is important in understanding health, medicine, the role of 763114-26-7, and how the biochemistry of the body works.Recommanded Product: 2-Fluoro-5-((4-oxo-3,4-dihydrophthalazin-1-yl)methyl)benzoic acid
Reference£º
Phthalazine – Wikipedia,
Phthalazine | C8H6N772 – PubChem